Company: ARTL
Filing Date: 2025-07-11
Form Type: S-1
Source: 0001640334-25-001190
Chunk: 31

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-07-11
Form: S-1
Chunk 31
---
 shown in the table is based on an aggregate of 704,425 shares of our Common Stock outstanding as June 30, 2025.

Beneficial ownership is determined according to the rules of the SEC, which generally provide that a person has beneficial ownership of a security if he, she or it possesses sole or shared voting or investment power over that security. Under those rules, beneficial ownership includes securities that the individual or entity has the right to acquire, such as through the exercise of stock options, within 60 days of June 30, 2025. Shares subject to options that are currently exercisable or exercisable within 60 days of June 30, 2025 are considered outstanding and beneficially owned by the person holding such options for the purpose of computing the percentage ownership of that person but are not treated as outstanding for the purpose of computing the percentage ownership of any other person. Except as noted by footnote, and subject to community property laws where applicable, based on the information provided to us, we believe that the persons and entities named in the table below have sole voting and investment power with respect to all shares shown as beneficially owned by them.

| 20 |

Unless otherwise indicated, the persons or entities identified in this table have sole voting and investment power with respect to all shares shown as beneficially owned by them, subject to applicable community property laws. Except as otherwise noted below, the address of each of the individuals and entities named in the table below is c/o Artelo Biosciences, Inc., 505 Lomas Santa Fe, Suite 160, Solana Beach, California 92075.

| Name and Address of Beneficial Owner                           |     | Shares |        |     | Percentage |     |   |
| 5% Stockholders:                                               |     |        |        |     |            |     |   |
| None                                                           |     |        |        |     |            |     |   |
| Other Directors and Named Executive Officers:                  |     |        |        |     |            |     |   |
| Gregory D. Gorgas(1)                                           |     |        | 25,736 |     |            | 3.7 | % |
| Connie Matsui(2)                                               |     |        |  1,788 |     | *          |     |   |
| Steven Kelly(3)                                                |     |        |  1,199 |     | *          |     |   |
| Douglas Blayney, M.D.(